ES443524A1 - Procedure for the preparation of analogous compounds of prostanic acids that do not exist in nature. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for the preparation of analogous compounds of prostanic acids that do not exist in nature. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES443524A1
ES443524A1 ES443524A ES443524A ES443524A1 ES 443524 A1 ES443524 A1 ES 443524A1 ES 443524 A ES443524 A ES 443524A ES 443524 A ES443524 A ES 443524A ES 443524 A1 ES443524 A1 ES 443524A1
Authority
ES
Spain
Prior art keywords
carbon atoms
formula
case
substituted
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES443524A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES443524A1 publication Critical patent/ES443524A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)

Abstract

Procedure for the preparation of analog compounds of prostanoic acids that do not exist in nature »of formula I **(See formula)** comprising both optically active compounds of the natural configuration, as well as racemic compounds, and in which R1 and R2 together signify oxygen, or each of them hydrogen or a hydroxyl group, R1 and R2 being different, R3 and R4 signify each hydrogen or a hydroxyl group, R3 and R4 being different, X signifies a straight or branched chain alcohol radical, with 1-5 carbon atoms, or a phenyl or benzyl radical, which may be trifluoro methyl, hydroxyl, alcohol and/or alkoxy with 1-4 carbon atoms in each case, R5 in the event that X is a straight or branched chain alcohol radical, with 1-5 carbon atoms, means a diphenyl ether, which is either unsubstituted or which is substituted in one or both nuclei from one to three times with halogen, trifluoromethyl, hydroxyl, alcohol and/or alkoxy with 1-4 carbon atoms in each case, or a phenoxyalkylone radical substituted in the nucleus or substituted from 1 to 3 times with ha logeno, trifluoromethyl, hydroxyl, alcohol and/or alkoxy with 1-4 carbon atoms in each case, where the straight chain alcohol radical contains 2-5 carbon atoms, or is branched and contains 3-6 carbon atoms, or in the case of X represents a substituted or unsubstituted phenyl radical, it means a benzyl radical that can be substituted 1 to 3 times in the nucleus with halogen, trifluoromethyl, hydroxyl, alcohol and/or alkoxy with 1-4 atoms of carbon in each case, or in the case that X is a substituted or unsubstituted benzyl radical, means a phenyl radical that can be substituted in the nucleus from 1 to 3 times with halogen, trifluoromethyl, hydroxyl, alcohol and/or alkoxy with 1-4 carbon atoms in each case, and in which carbon atoms 5 and 6, as well as 13 and 14, are all linked either by single or double bonds and their salts are physiologically compatible with organic bases and inorganic as well as its esters with ali alcohols phatic, cycloaliphatic or araliphatic with 1-8 carbon atoms in the ester part, characterized in that the tetrahydropyranyl protecting groups in a compound of formula X **(See formula)** or in a compound of formula XI **(See formula)** in which X and R5 have the same meanings as in formula I, they are separated by acid hydrolysis, and the compound of formula I obtained is eventually hydrogenated to form a compound of formula I in which there are single bonds at the positions 5 (6) and 13 (14), and if desired, the compound of formula I, in which there are in each case single or double bonds at positions 5 (6) and 13 (14), is transformed into a physiologically compatible salt or in an ester. (Machine-translation by Google Translate, not legally binding)
ES443524A 1974-12-21 1975-12-16 Procedure for the preparation of analogous compounds of prostanic acids that do not exist in nature. (Machine-translation by Google Translate, not legally binding) Expired ES443524A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460990 DE2460990A1 (en) 1974-12-21 1974-12-21 NEW PROSTAGLANDIN ANALOGS AND PROCEDURES FOR THEIR PRODUCTION

Publications (1)

Publication Number Publication Date
ES443524A1 true ES443524A1 (en) 1977-05-01

Family

ID=5934352

Family Applications (1)

Application Number Title Priority Date Filing Date
ES443524A Expired ES443524A1 (en) 1974-12-21 1975-12-16 Procedure for the preparation of analogous compounds of prostanic acids that do not exist in nature. (Machine-translation by Google Translate, not legally binding)

Country Status (11)

Country Link
JP (1) JPS5186449A (en)
AU (1) AU8772775A (en)
BE (1) BE836950A (en)
DE (1) DE2460990A1 (en)
DK (1) DK581075A (en)
ES (1) ES443524A1 (en)
FR (1) FR2294696A1 (en)
LU (1) LU74076A1 (en)
NL (1) NL7514654A (en)
SE (1) SE7514447L (en)
ZA (1) ZA757872B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4212985A (en) * 1978-04-28 1980-07-15 The Upjohn Company cis-4,5-Didehydro-16-phenoxy-PGE1 compounds
DE69832513T2 (en) * 1997-09-09 2006-07-13 Duke University AROMATIC C16-C20 SUBSTITUTED TETRAHYDRO PROSTAGLANDINES USE AS FP AGONISTE
PL339221A1 (en) * 1997-09-09 2000-12-04 Procter & Gamble Aromatic c16-c20-substituted tetrahydroprostaglandines useful as fp agonists
DE69824966T2 (en) * 1997-09-09 2005-04-07 Duke University AROMATIC C16-C20-SUBSTITUTED TETRAHYDRO-PROSTAGLANDINE USES AS FP AGONISTE
US6444840B1 (en) 1998-03-31 2002-09-03 The Procter & Gamble Co. C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists
KR20010042286A (en) 1998-03-31 2001-05-25 데이비드 엠 모이어 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
BR0008776A (en) 1999-03-05 2001-12-18 Procter & Gamble C16 fp-selective unsaturated prostaglandin analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
CA3045407C (en) 2009-07-29 2024-03-12 Elise A. Olsen Compositions and methods for inhibiting hair growth

Also Published As

Publication number Publication date
FR2294696A1 (en) 1976-07-16
BE836950A (en) 1976-06-22
ZA757872B (en) 1976-11-24
SE7514447L (en) 1976-06-22
DE2460990A1 (en) 1976-07-01
DK581075A (en) 1976-06-22
NL7514654A (en) 1976-06-23
JPS5186449A (en) 1976-07-29
FR2294696B1 (en) 1978-07-28
AU8772775A (en) 1977-06-23
LU74076A1 (en) 1976-11-11

Similar Documents

Publication Publication Date Title
ES443524A1 (en) Procedure for the preparation of analogous compounds of prostanic acids that do not exist in nature. (Machine-translation by Google Translate, not legally binding)
ES470408A1 (en) Tetracyclic derivatives and pharmaceutical compositions of matter
DE69100079D1 (en) NAPHTHALINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
KR830005187A (en) Method for preparing aminocyclopentane alkenoic acid and esters
ES449162A1 (en) 16-Phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
ES431516A1 (en) Procedure for the preparation of 2- (heterdanilmetilo 5,9-beta-dialcohil-6,7- benzonortanos. (Machine-translation by Google Translate, not legally binding)
SE7906472L (en) NEW 3- (AMINOETHYL) -PHENOL DERIVATIVES AND SALTS THEREOF, SET FOR PREPARATION AND USE OF THEM AS MEDICINAL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
ATE38T1 (en) AROYILUREA, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN INSECTICIDES AND ACARICIDES.
ES419936A1 (en) 1-hydroxy-1-((4'-hydroxy-3'aminosulfonamido)-phenyl)-2-amino-ethanes and salts
ES403080A1 (en) Aminothiophene-carboxylic acid esters
ES396495A2 (en) Procedure for the preparation of new derivatives of thiophene-acetic acid. (Machine-translation by Google Translate, not legally binding)
ES400790A1 (en) Procedure for the preparation of new acids 4- (4-bifenilil) - 4 - hydroxibutirics, its esteres or lactonas. (Machine-translation by Google Translate, not legally binding)
SE7900601L (en) 1-NAFTHYL-ETHIC ACID DERIVATIVE AND PROCEDURES FOR THEIR PREPARATION
ES445200A1 (en) Procedure for the preparation of new analogy compounds of prostanic acids. (Machine-translation by Google Translate, not legally binding)
ES436218A1 (en) Phenoxyalkanol derivatives and a process for their preparation
ES389921A1 (en) N-(hydroxy-or methoxy-alkyl)-2-(n'-(hydroxy or methoxy-alkyl)-phenyl-amino)-imidazolines-(2) and salts thereof
ES442024A1 (en) Phenylpropanolamines
ES406128A1 (en) Procedure for the preparation of 4 - (4 - bifenilil) - butirrics and their steres. (Machine-translation by Google Translate, not legally binding)
GB2001974A (en) Vincinic acid derivatives and process for the preparation thereof
ES452391A1 (en) Benzisothiazoline-1,1-dioxide derivatives, compositions and methods
SE8107347L (en) NEW 16-AMINO-18,19,20-TRINOR-PROSTAGLAND INGREDIENTS, ACID ADDITION SALTS THEREOF AND SET FOR THEIR PREPARATION
ES445343A1 (en) Quaternary xanthinylalkyl nortropine
ES391913A1 (en) A procedure to prepare new compounds of sulfonilurea or its salts. (Machine-translation by Google Translate, not legally binding)
ES432464A1 (en) Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them
SE7707367L (en) WAY TO PRODUCE NEW GLYCINAMIDES